Home > Drug List > Osimertinib > Prices of Osimertinib

Prices of Osimertinib

Osimertinib is developed and produced by the British pharmaceutical company AstraZeneca, mainly used to treat EGFR (epidermal growth factor receptor) mutation positive non-small cell lung cancer (NSCLC) patients. As a third-generation EGFR inhibitor, it can effectively inhibit the growth of tumor cells and provide better therapeutic effects.

The Lucius version of Osimertinib generic drug has a drug specification of 80mg * 30tablets and a price of approximately $138. The price of Osimertinib versions produced by different countries and pharmaceutical companies may vary, and the specific price may be affected by various factors such as market supply and demand, exchange rate fluctuations, etc.